B M Wittig1, M Zeitz. 1. First Department of Internal Medicine (Gastroenterology, Infectiology, Rheumatology), Universitätsklinik Benjamin Franklin, Freie Universität Berlin, Hindenburgdamm 30, 12200 Berlin, Germany. bianca.wittig@medizin.fu-berlin.de
Abstract
BACKGROUND: In normal conditions human gut mucosa is infiltrated with a large number of mononuclear cells due to continuous stimulation by luminal antigens. This state of "physiological" inflammation is tightly controlled, as several mucosal cells interact to maintain an appropriate local immune response. Moreover, gut-associated lymphoid tissue must constantly distinguish harmless antigens that are present in food and on commensal bacteria from pathogenic microbes. INTERVENTIONS AND RESEARCH: The oral administration of soluble protein antigens induces a state of systemic immunological unresponsiveness specific to the fed protein, termed oral tolerance. The two major mechanisms to explain oral tolerance are anergy/deletion of autoreactive lymphocytes and active suppression. Changes in the pathways of immune activation are detected in chronic intestinal inflammation, such as inflammatory bowel disease or celiac disease. CONCLUSION: An appreciation of the current knowledge of the gut immune system is of importance for understanding and development of new treatment modalities in chronic intestinal inflammation.
BACKGROUND: In normal conditions human gut mucosa is infiltrated with a large number of mononuclear cells due to continuous stimulation by luminal antigens. This state of "physiological" inflammation is tightly controlled, as several mucosal cells interact to maintain an appropriate local immune response. Moreover, gut-associated lymphoid tissue must constantly distinguish harmless antigens that are present in food and on commensal bacteria from pathogenic microbes. INTERVENTIONS AND RESEARCH: The oral administration of soluble protein antigens induces a state of systemic immunological unresponsiveness specific to the fed protein, termed oral tolerance. The two major mechanisms to explain oral tolerance are anergy/deletion of autoreactive lymphocytes and active suppression. Changes in the pathways of immune activation are detected in chronic intestinal inflammation, such as inflammatory bowel disease or celiac disease. CONCLUSION: An appreciation of the current knowledge of the gut immune system is of importance for understanding and development of new treatment modalities in chronic intestinal inflammation.
Authors: Stefan Farkas; Matthias Hornung; Christine Sattler; Karoline Edtinger; Markus Steinbauer; Matthias Anthuber; Hans J Schlitt; Hans Herfarth; Edward K Geissler Journal: Int J Colorectal Dis Date: 2005-04-23 Impact factor: 2.571
Authors: S Farkas; M Hornung; C Sattler; M Anthuber; U Gunthert; H Herfarth; H J Schlitt; E K Geissler; B M Wittig Journal: Clin Exp Immunol Date: 2005-11 Impact factor: 4.330
Authors: Y Junker; H Bode; U Wahnschaffe; A Kroesen; C Loddenkemper; R Duchmann; M Zeitz; R Ullrich Journal: Clin Exp Immunol Date: 2009-01-22 Impact factor: 4.330
Authors: Carlos A Rubio; Jurate Ásmundsson; Pedro Silva; Christofer Illies; Johan Hartman; Lorand Kis Journal: Virchows Arch Date: 2013-08-25 Impact factor: 4.064